Articles by Jim Cirigliano

Synthetic antibiotic shows efficacy against priority antibiotic-resistant pathogen

New compound may help reduce chronic opioid use and facilitate dose tapering

Rice team publishes simple aziridination method for synthesizing pharmaceutical building blocks

Liquid biopsy aims to accelerate biomarker-driven precision cancer therapies

New application helps authors, publishers address heightened reproducibility and transparency standards

Phase 2 trial evaluates a new tool in pediatric cancer immunotherapy

French biotech company raises €6.2M for gut microbiome R&D

Two enzymes indicted in inflammation and tumor growth in non-small cell lung carcinomas

Breakthrough research identifies a potential vaccine against deadly fungus

Expanded collaboration in Huntington’s disease research to explore stem cell and genetic therapeutics

Staphyloccocus genes offer potential pathways for overcoming antibacterial resistance

Shingles treatment the first of several herpesvirus drug candidates to enter IND-enabling studies

Companies will focus on gene-silencing targets in the areas of cardio-metabolic disease, neurodegeneration and pain

BLU-782 offers hope for patients with difficult-to-target genetic disease that turns muscle to bone

Cells reverting to ‘fetal program’ may accelerate wound healing